Eric J Ende

CIK 1494386 · last filed 2026-02-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$93.7K

Companies

5

Total Filings

46

Lifetime Open-Market Net

$1.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Director 0 $21.64 $0 $1.05M 20 2026-02-12
MTNB Director 120,092 $0.78 $93.7K $26.9K 19 2023-11-03
NeuBase Therapeutics, Inc. (NBSE) Delisted Director $0.38 $0 2 2022-09-12
PROGENICS PHARMACEUTICALS INC (PGNX) Delisted Director $0 2 2019-12-17
GENZYME CORP (GENZ) Delisted Director 2,375 $0 2 2011-04-06

Recent Filings · Page 5 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-04-02 MTNB Grant (A) +11,760 $0 EDGAR
2018-02-27 MTNB Grant (A) $0 EDGAR
2017-07-19 MTNB Grant (A) $0 EDGAR
2017-04-21 MTNB Grant (A) $0 EDGAR
2011-04-06 GENZYME CORP (GENZ) Delisted Mixed -$175.8K EDGAR
2010-06-18 GENZYME CORP (GENZ) Delisted Grant (A) $0 EDGAR
Showing 4146 of 46
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.